Stoke Share Price

Stoke Share Price

NASDAQ: STOK | Small Cap | Healthcare
$26.78
-$0.15 (-0.56%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Stoke Stock Performance

Open
$26.90
Prev. Close
$26.93
Circuit Range
N/A
Day Range
$26.55 - $27.53
Year Range
$22.34 - $40.19
Volume
27,574
Average Traded
$26.93

Stoke Share Price Today

As of 21 November 2026, Stoke Therapeutics, Inc.'s share price is $26.78. The stock opened at $26.90, compared to its previous close of $26.93. During today's trading session, Stoke Therapeutics, Inc.'s share price traded between $26.55 and $27.53, with an average price of $27.04. Over the past 52 weeks, the stock has recorded a high of $40.19 and a low of $22.34. In terms of performance, Stoke Therapeutics, Inc.'s share price has declined by 13.29% over the last six months and is down 13.70% on a year-on-year basis.

Stoke Share Price Chart

Line chart of the Stoke price trend over the selected period. The price fell overall, ranging from 26.36 to 27.58, ending at 26.78.
$26.55$27.53
L
Show Current Price
H

Stoke Stock Fundamentals & Key Indicators

Market Cap
$1.59B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.72
Revenue (TTM)
$184.42B
Return On Equity (TTM)
-68.98%
Profit Margin
-3.74%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-27.12%

Stoke Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.40$6.23$9.33$11.26
Net Profit-$57.93-$50.00-$61.62-$73.64
Net Profit Margin-4137.86%-802.57%-660.45%-654.00%
Income ChangeN/A13.69%-23.24%-19.51%

Stoke Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$12.41$8.78$36.56$184.42
Net Profit-$101.07-$104.70-$88.98-$6.89
Net Profit Margin-814.42%-1192.48%-243.38%-3.74%
Income ChangeN/A-3.59%15.01%92.26%

Stoke Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets112.7338.813.012.0
Current Assets305.7232.76215.34244.07
Total Assets418.43271.56228.34256.07
Non Current Liabilities8.12.4837.9639.82
Current Liabilities57.8840.0630.8231.39
Total Liabilities65.9842.5368.7871.22
Shareholders' Equity352.46229.02159.57184.85

Stoke Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating45.59-86.85-81.07-31.87
Investing-186.81-107.48105.95-45.88
Financing97.39131.0953.0146.41

About Stoke

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Stoke Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$26.38
$26.74
+1.63%
Oct 2026
$26.07
$26.31
+1.02%
Sep 2026
$30.72
$26.05
-20.19%
Aug 2026
$28.94
$32.63
+13.10%
Jul 2026
$33.26
$28.86
-11.83%
Jun 2026
$30.71
$32.73
+5.96%
May 2026
$33.14
$30.89
-5.55%
Apr 2026
$32.97
$32.70
+0.54%
Mar 2026
$36.06
$32.52
-10.77%
Feb 2026
$29.95
$36.45
+20.06%
Jan 2026
$31.43
$30.36
-4.26%
Dec 2025
$30.52
$31.71
+2.19%

Stoke Share Price FAQs